Frontlight ResearchEarly access
Taking people in PolandPhase 1
Virus-fighting T-cell therapy for cytomegalovirus infection after stem cell transplant
Tests the safety of virus-specific T cells against resistant cytomegalovirus in adult transplant patients.
Key facts
- Who runs it
- Wroclaw Medical University
- Where
- Gdansk, Krakow, Poznan, Warsaw, and Wroclaw, PolandSee the 6 sites
- Trial code
- Registry title
- A multicenter, open-label, dose-escalation clinical trial to evaluate the safety of viral-specific T-cell (VST) therapy in the treatment of refractory viral infections after allogeneic hematopoietic stem cell transplantation or CAR-T therapy (ALLOVISTA).
- Status
- Recruiting
- Phase
- Phase 1
- People taking part
- 18 people, planned
- Started
- 15 Jul 2026
- Expected to end
- 30 Jun 2029
- Type of study
- Interventional
- Record updated
- 7 July 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with a CMV (cytomegalovirus) infection that does not respond to treatment. Their infection must have come after a stem cell transplant from a donor or after CAR-T therapy.
- Age
- 18 years and older
- Sex
- All sexes
- Disease stage
- Viral infection that does not respond to treatment (refractory), after a donor stem cell transplant or CAR-T therapy
- Earlier treatment
- Must have had a donor (allogeneic) stem cell transplant or CAR-T therapy
Where in Poland
- Uniwersyteckie Centrum KliniczneGdansk, PolandTaking people
- Szpital Uniwersytecki w KrakowieKrakow, PolandTaking people
- Uniwersytecki Szpital Kliniczny w PoznaniuPoznan, PolandTaking people
- Instytut Hematologii I TransfuzjologiiWarsaw, PolandTaking people
- Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu MedycznegoWarsaw, PolandTaking people
- Uniwersytecki Szpital Kliniczny im Jana Mikulicza Radeckiego we WroclawiuWroclaw, PolandTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorData and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
- Plain-language title
- Virus-fighting T-cell therapy for cytomegalovirus infection after stem cell transplantGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 7 July 2026